COMMUNIQUÉS West-GlobeNewswire

GUERBET : Chiffre d'affaires au 30 septembre 2017

25/10/2017 - 17:48

597,4 M€ à taux de change constant : +5,1% Niveau d'activité conforme aux anticipations Villepinte, le 25 octobre 2017 - Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l' [...]

GUERBET : Revenue at September 30, 2017

25/10/2017 - 17:48

€597.4 million at constant exchange rates: +5.1% Level of activity in line with expectations Villepinte, October 25, 2017 - Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical [...]

Advance Notice: EastPharma Ltd Sales Update Announcement for the period 30 September 2017

25/10/2017 - 17:43

EASTPHARMA LTD. London, 25 October 2017 - EastPharma (EAST LI) informs that it will be releasing its 9M 2017 sales performance and a review of its main subsidiary DEVA Holding's unaudited financial statements for the [...]

Novartis confirms leadership in multiple sclerosis (MS) with scientific advancements and new data presented at ECTRIMS

25/10/2017 - 17:30

Full data from the pivotal Phase III PARADIGMS study of Gilenya ® (fingolimod) in pediatric MS will be presented for the first time With 54 accepted abstracts, Novartis presence spans from new siponimod (BAF312) data in [...]

AbCheck and Molecular Templates Announce Collaboration to Discover Therapeutic Oncology Leads

25/10/2017 - 16:11

Plzen, Czech Republic, and Austin, TX, USA, October 25, 2017 - AbCheck s.r.o., a technology company focusing on the discovery and optimization of high-quality human antibodies, and Molecular Templates Inc., a publicly [...]

Medtronic Announces First Economic Analysis Demonstrating Benefits of Professional CGM in People with Type 2 Diabetes

25/10/2017 - 15:00

DUBLIN - October 25, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced data from the first economic analysis conducted on the use of professional continuous glucose monitoring ( [...]

Summit Therapeutics plc : Grant of share options

25/10/2017 - 15:00

Summit Therapeutics plc ('Summit' or the 'Company') GRANT OF SHARE OPTIONS TO DIRECTORS, PDMRS AND EMPLOYEES AND GRANT OF RESTRICTED STOCK UNITS TO NON-EXECUTIVE DIRECTORS Oxford, UK, 25 October 2017 - Summit [...]

CapsoVision, Inc. Announces CE Mark for the Use of CapsoCam Plus Capsule Endoscopy System in Patients Ages 2 and Above

25/10/2017 - 14:00

Award-winning technology provides 360º imaging, eliminates need for receiver equipment during examination SARATOGA, Calif., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Today Silicon Valley-based CapsoVision, Inc. announced CE [...]

SUSPENSION OF TRADING IN ABLYNX SHARES ON EURONEXT BRUSSELS

25/10/2017 - 13:09

REGULATED INFORMATION GHENT, Belgium, 25 October 2017 (1 pm CEST) - Trading in the shares of Ablynx NV [Euronext Brussels: ABLX; OTC: ABYLY] was suspended at the request of the Company on 25 October 2017 as from 1 pm [...]

Shire Receives Orphan Drug Designation for Gene Therapy Candidate SHP654 (BAX 888) for the Treatment of Hemophilia A

25/10/2017 - 13:00

Shire Receives Orphan Drug Designation for Gene Therapy Candidate SHP654 (BAX 888) for the Treatment of Hemophilia A SHP654 investigational new drug (IND) application accepted by the FDA Lexington, MA - October 25, 2017 [...]

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

25/10/2017 - 09:00

FIT Biotech Oy Company release October 25, 2017 at 10:00 AM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on September 26, 2016 [...]

Ambu acquires Invendo Medical and enters market of 70 million gastro procedures annually

25/10/2017 - 08:33

Ambu fast-forwards it's single-use endoscopy business. The purchase price of EUR 225 million includes contingent payments of up to EUR 110 million. Today, Ambu has acquired Invendo Medical GmbH. Invendo Medical is a [...]

CellaVision AB: Interim report January - September 2017

25/10/2017 - 08:20

An in-between quarter though with stronger market presence as well as product sales approval in the USA 1 juli-30 september 2017 1 januari-30 september 2017 Net sales decreased by 10 % to SEK 61.3 million (68.3) Organic [...]

Nexstim raises EUR 1.75 million via a directed issue of new shares to London-based investor City Financial - Funds to be used to support beginning the commercialisation of its NBT® system

25/10/2017 - 08:00

Company announcement, Helsinki, 25 October 2017 at 9:00 am Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or " Company "), a medical technology company developing and marketing pioneering navigated non-invasive brain [...]

uniQure Announces Pricing of its Public Offering

25/10/2017 - 02:14

LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Oct. 24, 2017 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leading gene therapy company advancing transformative therapies for patients with severe unmet medical [...]

ABLYNX PRICES $200 MILLION INITIAL PUBLIC OFFERING IN THE UNITED STATES

25/10/2017 - 02:07

REGULATED INFORMATION - INSIDE INFORMATION 25 October 2017 - 2 am CEST GHENT, Belgium, 25 October 2017 - Ablynx NV [Euronext Brussels: ABLX; OTC: ABYLY] , a late-stage clinical biopharmaceutical company utilising its [...]

Stryker to acquire VEXIM

24/10/2017 - 22:00

Kalamazoo, Michigan - October 24, 2017 - Stryker Corporation (NYSE:SYK) announced that it has acquired control of VEXIM, a French medical device company listed on the Euronext Growth stock exchange in France. VEXIM, [...]

Sanofi Files Suit in the U.S. to Defend Its Patent Rights on Lantus® and Lantus® SoloStar®

24/10/2017 - 22:04

Sanofi Files Suit in the U.S. to Defend Its Patent Rights on Lantus ® and Lantus ® SoloStar ® Paris, France - October 24, 2017 - Sanofi (EURONEXT: SAN and NYSE: SNY) today filed a patent infringement suit against Mylan [...]

Sanofi intente une action en justice aux États-Unis pour défendre les brevets de Lantus® et de Lantus® SoloStar®

24/10/2017 - 22:04

Sanofi intente une action en justice aux États-Unis pour défendre les brevets de Lantus ® et de Lantus ® SoloStar ® Paris, France - Le 24 octobre 2017 - Sanofi (EURONEXT: SAN et NYSE: SNY) annonce aujourd'hui avoir [...]